[Medicines for Malaria Venture] EDCTP grants the PAMAfrica research consortium €21.9 million over a 5 year period; MMV, Novartis and other partners will provide an additional €22 million. The PAMAfrica consortium brings together a global medicines company, a not-for-profit product development partnership and leading academic institutions in Africa and Europe. PAMAfrica aims to develop new […] Continue reading ->
Funding to develop new drugs for some of the world’s leading infectious disease killers, such as HIV/AIDS, TB and malaria, reached a record high of US $4 billion in 2018, with private sector investment driving much of the increase, according to the 2019 G-FINDER Report, which tracks such investments globally. However, investments in neglected tropical […] Continue reading ->
With some 4.2 million deaths worldwide from outdoor air pollution, and many or most cities in low- and middle-income countries failing to meet World Health Organization air quality guidelines, it’s clear that reducing air pollution’s huge death toll needs rapid action by urban centers. But officials and administrators of fast-growing municipalities often lack the right […] Continue reading ->
More than one-third of low- and middle-income countries worldwide are facing significant rates of obesity alongside continued pockets of undernutrition, according to a major new study published on Monday in The Lancet. The four-part series The Double Burden of Malnutrition, led by the World Health Organization in collaboration with a number of universities and researchers […] Continue reading ->
For the first time ever, leading cancer organizations across Latin America have signed onto a joint declaration pledging to intensify action against millions of avoidable cancer deaths on the continent. The Bogota Statement on Leading BOLD Cancer Prevention into the Future was signed by leaders of cancer organizations and foundations from 8 Latin American countries, […] Continue reading ->
MMV CEO David Reddy talks about the steps MMV is taking to support a new generation of malaria research leadership, promote more gender-sensitive malaria treatment and fast-track innovation on new malaria combination therapies. This follows a string of MMV successes over the past two decades in fostering new paediatric malaria treatments, new combination therapies to […] Continue reading ->
Lyon, France – The global health community needs to scale-up collaborations with product development partnerships (PDPs) that could bring life-saving innovations for prevention, diagnosis, and treatment of HIV/AIDS, Malaria and Tuberculosis to market faster, said health experts at a side event ahead of the Global Fund’s Sixth Replenishment Conference. There are some 55 “potentially transformative” […] Continue reading ->